Product Description
Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist commonly used in research to explore growth hormone–related signaling pathways.
In controlled laboratory studies, it exhibits targeted GH stimulation with minimal interaction with cortisol or prolactin pathways, making it a valuable model compound for examining metabolic regulation, musculoskeletal signaling, and cellular recovery mechanisms.
Potential Benefits Suggested in Research Models
Ipamorelin – Preclinical Research Observations
- Studied for stimulating GH-related signaling pathways
- Explored for support of lean-muscle signaling activity
- Investigated for recovery and tissue-repair pathway enhancement
- Studied for improved metabolic-function signaling
- Explored for fat-metabolism modulation
- Investigated for anti-inflammatory pathway interactions
- Examined for promoting IGF-1–related downstream activity
- Studied for neuroprotective-signaling support in certain laboratory models
Key Research Advantages
- Selective ghrelin receptor activation
- Minimal off-target hormonal interaction in preclinical studies
- Stable and predictable dose-response curves
- Highly pure synthetic peptide suitable for precise research applications
Product Features
- ≥ 99% purity (HPLC verified)
- Lyophilized for extended laboratory shelf life
- Synthetic pentapeptide structure
- Batch-tested for identity, potency, and structural integrity
Research Use Only
Not for human use.
Not for medical, therapeutic, or diagnostic purposes.
















Reviews
There are no reviews yet